JPWO2023042879A5 - - Google Patents

Info

Publication number
JPWO2023042879A5
JPWO2023042879A5 JP2023548502A JP2023548502A JPWO2023042879A5 JP WO2023042879 A5 JPWO2023042879 A5 JP WO2023042879A5 JP 2023548502 A JP2023548502 A JP 2023548502A JP 2023548502 A JP2023548502 A JP 2023548502A JP WO2023042879 A5 JPWO2023042879 A5 JP WO2023042879A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
aromatic heterocyclic
hydrogen atom
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548502A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023042879A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/034552 external-priority patent/WO2023042879A1/ja
Publication of JPWO2023042879A1 publication Critical patent/JPWO2023042879A1/ja
Publication of JPWO2023042879A5 publication Critical patent/JPWO2023042879A5/ja
Pending legal-status Critical Current

Links

JP2023548502A 2021-09-17 2022-09-15 Pending JPWO2023042879A1 (https=)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021152086 2021-09-17
JP2021191637 2021-11-26
JP2022093120 2022-06-08
PCT/JP2022/034552 WO2023042879A1 (ja) 2021-09-17 2022-09-15 ウイルス増殖阻害活性を有する二環性複素環誘導体およびそれらを含有する医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023042879A1 JPWO2023042879A1 (https=) 2023-03-23
JPWO2023042879A5 true JPWO2023042879A5 (https=) 2025-08-19

Family

ID=85602970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548502A Pending JPWO2023042879A1 (https=) 2021-09-17 2022-09-15

Country Status (3)

Country Link
US (1) US20240400560A1 (https=)
JP (1) JPWO2023042879A1 (https=)
WO (1) WO2023042879A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021330835B2 (en) 2020-08-24 2023-12-14 Gilead Sciences, Inc. Phospholipid compounds and uses thereof
TW202344257A (zh) 2020-10-16 2023-11-16 美商基利科學股份有限公司 磷脂化合物及其用途
TW202408511A (zh) 2022-08-05 2024-03-01 美商基利科學股份有限公司 Ｓａｒｓ－ｃｏｖ２主蛋白酶抑制劑
WO2024104441A1 (en) * 2022-11-17 2024-05-23 Insilico Medicine Ip Limited Salt-inducible kinases (sik) inhibitors and methods of uses thereof
WO2024228401A1 (ja) * 2023-05-02 2024-11-07 国立大学法人 大分大学 新型コロナウイルス感染症の処置または予防用医薬としての置換三環式複素環化合物
CN116621817B (zh) * 2023-07-20 2023-09-29 爱斯特（成都）生物制药股份有限公司 一种富马酸恩赛特韦的晶型及其制备方法、药物组合物和用途
CN119101031A (zh) * 2023-09-08 2024-12-10 北京华益健康药物研究中心 用于治疗或预防冠状病毒感染的3cl蛋白酶抑制剂及其用途
CN119101030A (zh) * 2023-09-08 2024-12-10 北京华益健康药物研究中心 用于治疗或预防冠状病毒感染的3cl蛋白酶抑制剂及其用途
WO2025074997A1 (ja) * 2023-10-02 2025-04-10 塩野義製薬株式会社 ウイルス増殖阻害活性を有する縮合複素環誘導体およびそれらを含有する医薬組成物
US20250276979A1 (en) * 2024-02-07 2025-09-04 Gilead Sciences, Inc. Sars-cov2 main protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264437A (en) * 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
US5624926A (en) * 1993-02-18 1997-04-29 Kyowa Hakko Kogyo Co., Ltd. Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
JP2000119272A (ja) * 1998-10-15 2000-04-25 Nippon Zoki Pharmaceut Co Ltd 新規７−アミノピリド〔２，３−ｄ〕ピリミジン誘導体
TW200726767A (en) * 2005-07-04 2007-07-16 Astrazeneca Ab Chemical compounds 2
KR100817538B1 (ko) * 2006-07-05 2008-03-27 한국화학연구원 신규 치환된―１ｈ―퀴나졸린―２,４―디온 유도체, 이의제조방법 및 이를 함유하는 약학적 조성물
CN110621317B (zh) * 2017-05-16 2023-05-12 安基生技新药股份有限公司 组蛋白去乙酰化酶（hdacs）抑制剂
EP3774793B1 (en) * 2018-03-26 2022-02-23 Fondazione Per L'Istituto Oncologico Di Ricerca (IOR) New compounds with enhanced anti-tumor effects

Similar Documents

Publication Publication Date Title
JPWO2023042879A5 (https=)
US8436038B2 (en) Indole and indazole compounds as an inhibitor of cellular necrosis
DK2303021T3 (en) RELATIONSHIPS FOR TREATING CANCER
CN1942186B (zh) 吡咯烷化合物
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
JP2011513305A5 (https=)
JP2019094345A5 (https=)
JP2022506887A5 (https=)
RU2014153627A (ru) Имидазо[1, 2-]пиридазиновые производные как ингибиторы киназ
JP2018509418A5 (https=)
JPWO2020094104A5 (https=)
JP2007536224A5 (https=)
RU2005117789A (ru) Производные 4,5-диарилтиазола в качестве лигандов св-1
WO2009118567A3 (en) Pyrimidines, triazines and their use as kinase inhibitors
CA2582447A1 (en) Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2004175807A5 (https=)
JPWO2023106310A5 (https=)
AR073548A1 (es) Compuestos derivados de diazol y triazol, composiciones y uso de los mismos para modular los niveles de acido urico
RU2008116581A (ru) Сульфонамидные производные, как активаторы гликокиназы, применимые для лечения диабета типа 2
JP2010515750A5 (https=)
EP3227270A2 (en) Heterocyclic derivatives and use thereof
JPWO2023195529A5 (https=)
CO6331462A2 (es) Compuesto de fenil pirrol o una sal farmaceuticamente aceptable del mismo con actividad activadora de la glucoquinasa
JP2011513410A (ja) ピロリジン誘導体